Efficacy and Safety of Sofosbuvir and Ribavirin for Treating Chronic Hepatitis C, Genotype 3: Experience of a Tertiary Care Hospital at Karachi, Pakistan

Background It is estimated that approximately 10 million individuals in Pakistan are infected with hepatitis C virus (HCV). Historically, it was very difficult not just to cure but even treat HCV as available options did not have desirable outcomes. However, the approval of directly acting antiviral...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cureus
Hlavní autoři: Butt, Nazish, Reema, Sehrish, Ali Khan, M, Abbasi, Amanullah, Butt, Sehrish, Khoso, Mohammad M, Akbar, Ali, Haleem, Farhan, Mahesar, Ghulam B, Fahad, Anoshia, Qureshi, Talha
Médium: Artigo
Jazyk:Inglês
Vydáno: Cureus 2019
Témata:
Gastroenterology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6561614/
https://ncbi.nlm.nih.gov/pubmed/31205844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.4458
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky